Avadel Pharmaceuticals PLC

AVDLDelisted Feb 12, 2026

Industry: Pharmaceutical Preparations
SEC CIK: 0001012477

SEC filings (opens in a new tab)

Avadel Pharmaceuticals PLC was delisted on Feb 12, 2026; its insiders filed their last Form 4 on Feb 18, 2026; 208 institutions reported holding it in 13F filings for Q4 2025, worth $1.60B in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Avadel Pharmaceuticals PLC changed between Q1 2021 and Q2 2021.

All holders in Q2 2021 All holders in Q1 2021

13F holders of AVDL: Q1 2021 compared with Q2 2021
Measure	Q1 2021	Q2 2021	Change
Holders	77	80	+3
Shares	32.6M	32.6M	−63.6K (−0.2%)
Value	$294.4M	$219.1M	−$75.3M (−25.6%)

New holders (11)

Institutions that held Avadel Pharmaceuticals PLC at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to AVDL in Q2 2021
Institution	Shares	Value	% of portfolio
Woodline Partners LP	232,537	$1.56M	0.03%
Gsa Capital Partners LLP	52,933	$356.0K	0.04%
Engineers Gate Manager LP	13,800	$93.0K	0.01%
D. E. Shaw & Co., Inc.	13,636	$92.0K	0.00%
Jump Financial, LLC	13,712	$92.0K	0.01%
Envestnet Asset Management Inc	13,316	$90.0K	0.00%
Legacy Wealth Asset Management, LLC	13,000	$87.0K	0.04%
ProShare Advisors LLC	10,494	$71.0K	0.00%
ACT Capital Management, LLC	10,500	$71.0K	0.04%
The PNC Financial Services Group, Inc.	500	$3.00K	0.00%
Parallel Advisors, LLC	128	$1.00K	0.00%

Sold out (8)

Institutions that held Avadel Pharmaceuticals PLC at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of AVDL in Q2 2021
Institution	Shares, Q1 2021	Value, Q1 2021
California Public Employees Retirement System	117,600	$1.06M
Pictet Asset Management Ltd	99,764	$902.0K
HighVista Strategies LLC	93,059	$841.0K
Millennium Management LLC	32,378	$293.0K
Northern Trust Corp	20,781	$188.0K
Creative Planning	15,700	$142.0K
Parallax Volatility Advisers, L.P.	11,688	$106.0K
Wolverine Trading, LLC	10,274	$91.0K